Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls
Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls
复制标题
类风湿关节炎、早期未分类多关节炎和健康对照掌指关节的动态磁共振成像
DOI:
--
复制
发表时间:
2000
影响因子:
2.1
通讯作者:
I. Lorenzen
中科院分区:
文献类型:
--
作者:
M. Klarlund;M. Østergaard;E. Rostrup;H. Skjødt;I. Lorenzen
Objective. To introduce dynamic magnetic resonance imaging (MRI) as an indicator of inflammatory activity in the metacarpophalangeal (MCP) joints of patients with rheumatoid arthritis (RA) or early unclassified polyarthritis, and to compare the results with a healthy control group. Materials and Methods. We examined 42 RA and 23 early unclassified polyarthritis patients, and 12 healthy controls in a cross-sectional study. Dynamic MRI (repeated FLASH-MR images after injection of a contrast agent) was performed through the 2nd to the 5th MCP joint. Two methods for identification of the enhancing synovial membrane were compared: 1) outlining of enhancing synovial membrane on subtraction images and 2) automated recognition by principal component analysis (PCA). The early enhancement (EE) rate was calculated on the basis of the first method. Results. Method 1) and 2) were closely associated (P<0.00001). From the healthy control group, an upper limit (mean+2SD) of normal enhancement was established for the 2nd to 5th MCP joints, which served to identify abnormal EE rates in the corresponding joints of patients. The patients had higher EE rates in the 2nd to 5th MCP joints than had the healthy controls (P<0.01). There were no significant differences between the two patient groups (P>0.09). Conclusion. PCA seems to be a promising method for automated identification of enhancing tissue. EE rates of the finger joints may be useful in the assessment of the inflammatory activity in the joints of patients with RA and early unclassified polyarthritis and may reflect other aspects of disease activity than clinical evaluation.
影响因子:
--
作者:
Wallis,WJ;Simkin,PA;Nelp,WB
通讯作者:
Nelp,WB
影响因子:
4.9
作者:
Schäfer VS;Hartung W;Hoffstetter P;Berger J;Stroszczynski C;Müller M;Fleck M;Ehrenstein B
通讯作者:
Ehrenstein B